Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.95 |
| ▸ | CA2 | P00918 | 8/20 | 0.95 |
| ▸ | CA12 | O43570 | 5/20 | 0.95 |
| ▸ | CA7 | P43166 | 5/20 | 0.95 |
| ▸ | CA9 | Q16790 | 5/20 | 0.95 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.95 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | ESR1 | P03372 | 2/20 | 0.57 |
| ▸ | XDH | P47989 | 1/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.57 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylparaben SCHEMBL4440 | 0.98 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL321534 | 0.98 | CA1 (1.00) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL48757 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL21274302 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL1699480 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL8779118 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL475867 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL16029235 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL6315862 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 | |
| Methylparaben SCHEMBL31713879 | 0.95 | CA1 (0.95) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608929-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LyondellBasell Advanced Polymers Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-12338390-B2 | Bridging particle and fluid loss control agent | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2025-06-24 | — | — | US | claimed |
| US-20240228859-A9 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-07-11 | — | — | US | claimed |
| WO-2024091462-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-05-02 | — | — | WO | claimed |
| US-20240132772-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-04-25 | — | — | US | claimed |
| US-12545860-B2 | Mannanase variants | BASF SE (DE) | 2026-02-10 | — | — | US | disclosed |
| EP-4608929-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LyondellBasell Advanced Polymers Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| US-12338390-B2 | Bridging particle and fluid loss control agent | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2025-06-24 | — | — | US | disclosed |
| EP-4453838-A1 | ENVIRONMENTAL ATTRIBUTES FOR CARE COMPOSITION INGREDIENTS | BASF SE (DE) | 2024-10-30 | — | — | EP | disclosed |
| CN-118435218-A | Environmental attributes of the care composition ingredients | 巴斯夫欧洲公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20240228859-A9 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-07-11 | — | — | US | disclosed |
| WO-2024091462-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2021094127-A1 | A FABRIC CARE COMPOSITION COMPRISING HYDROPHOBICALLY MODIFIED POLYALKYLENEIMINE AND A BIOCIDE | BASF SE (DE) | 2021-05-20 | — | — | WO | disclosed |
| WO-2021074430-A1 | STORAGE-STABLE HYDROLASE CONTAINING LIQUIDS | BASF SE (DE) | 2021-04-22 | — | — | WO | disclosed |
| EP-2207416-B1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | IMERYS FILTRATION MINERALS INC (US) | 2018-11-07 | — | — | EP | disclosed |
| CN-105165823-A | Enhanced Retention Capabilities Through Methods Comprising Surface Treatment Of Functional Particulate Carrier Materials, And Functional Particulate Carrier Materials Made Therefrom | WORLD MINERALS INC | 2015-12-23 | — | — | CN | disclosed |
| CN-101883485-A | Enhanced retention through a process comprising surface treatment of functional particulate support materials and functional particulate support materials made therefrom | WORLD MINERALS INC | 2010-11-10 | — | — | CN | disclosed |
| US-20100239679-A1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | WORLD MINERALS, INC. (US) | 2010-09-23 | — | — | US | disclosed |
| EP-2207416-A1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | World Minerals, Inc. (US) | 2010-07-21 | — | — | EP | disclosed |
| WO-2009045941-A1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | WORLD MINERALS, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545860-B2 | Mannanase variants | MAN2A1, MANBA, IDUA | CA1 4163/4885CA2 4162/4885CA12 3172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.